PART 3Amendment of Part 3 (manufacture and distribution of medicinal products and active substances)

Amendment of regulation 17 (manufacturing of medicinal products)I114

1

Regulation 17 is amended as follows.

F22

For paragraph (1) substitute—

1

A person may not except in accordance with a licence (a “manufacturer’s licence”)—

a

manufacture a medicinal product,

b

assemble a medicinal product,

c

import a medicinal product into Great Britain from a country other than—

i

Northern Ireland, or

ii

an approved country for import,

d

import a medicinal product into Northern Ireland from a country other than an EEA State, or

e

possess a medicinal product for the purpose of any activity in sub-paragraphs (a) to (d).

F33

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F44

In paragraph (4), after sub-paragraph (a) insert—

aa

a UK marketing authorisation; or

F55

In paragraph (5) omit “from a state other than an EEA State”.

F16

After paragraph (6) insert—

7

Paragraph (1) does not apply to imports into Northern Ireland from Great Britain of—

a

special medicinal products, and

b

medicinal products that have been released for sale, supply or distribution in an EEA State or the United Kingdom before IP completion day.

8

For the purposes of paragraph (7) a medicinal product has been released for sale, supply or distribution where, after the stage of manufacturing has taken place, the product is the subject matter of a written or verbal agreement between two or more persons for the transfer of ownership, any other property right, or possession concerning the product, or where the product is the subject matter of an offer to a person to conclude such an agreement.